106 related articles for article (PubMed ID: 12615143)
1. Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line.
Murata T; Sugatani T; Shimizu K; Manganiello VC; Tagawa T
Arch Oral Biol; 2003 Jan; 48(1):63-7. PubMed ID: 12615143
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
4. Role of phosphodiesterase 4 isoenzyme in alkaline phosphatase activation by calcitonin in porcine kidney LLC-PK1 cells.
Miyamoto K; Suzuki R; Horita T; Yamamoto S; Waki Y; Takagi K
Jpn J Pharmacol; 1998 Feb; 76(2):193-8. PubMed ID: 9541282
[TBL] [Abstract][Full Text] [Related]
5. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
[TBL] [Abstract][Full Text] [Related]
6. The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function.
Miller AH; Vogt GJ; Pearce BD
Neuropsychopharmacology; 2002 Dec; 27(6):939-48. PubMed ID: 12464451
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
10. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
Gordeladze JO
Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
[TBL] [Abstract][Full Text] [Related]
12. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
Kochetkova M; Burns FM; Souness JE
Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase isozymes involved in regulating acid secretion in the isolated mouse stomach.
Okuda S; Honda M; Ito Y; Aihara E; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():183-90. PubMed ID: 20388963
[TBL] [Abstract][Full Text] [Related]
14. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
Sette C; Iona S; Conti M
J Biol Chem; 1994 Mar; 269(12):9245-52. PubMed ID: 8132662
[TBL] [Abstract][Full Text] [Related]
15. Type IV phosphodiesterase inhibitor suppresses insulin-dependent myocardial glucose uptake.
Imahashi K; Yoshioka J; Yamakita T; Yamano S; Kusuoka H; Nishimura T
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):290-1. PubMed ID: 11251642
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility.
Murata K; Sudo T; Kameyama M; Fukuoka H; Muka M; Doki Y; Sasaki Y; Ishikawa O; Kimura Y; Imaoka S
Clin Exp Metastasis; 2000; 18(7):599-604. PubMed ID: 11688965
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
[TBL] [Abstract][Full Text] [Related]
18. The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging.
Navakkode S; Sajikumar S; Frey JU
J Neurosci; 2004 Sep; 24(35):7740-4. PubMed ID: 15342741
[TBL] [Abstract][Full Text] [Related]
19. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
Cherry JA; Thompson BE; Pho V
Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
